O	0	1	A
O	2	12	systematic
O	13	24	correlation
O	25	27	of
B-Diagnostic_tool	28	39	angiography
O	40	43	and
B-Diagnostic_tool	44	48	high
I-Diagnostic_tool	48	49	-
I-Diagnostic_tool	49	59	resolution
I-Diagnostic_tool	60	67	optical
I-Diagnostic_tool	68	77	coherence
I-Diagnostic_tool	78	88	tomography
O	89	91	in
B-Disease	92	100	diabetic
I-Disease	101	108	macular
I-Disease	109	114	edema
O	114	115	.

O	117	119	To
O	120	129	correlate
O	130	137	leakage
O	138	146	patterns
O	147	149	in
B-Diagnostic_tool	150	161	fluorescein
I-Diagnostic_tool	162	173	angiography
I-Diagnostic_tool	174	175	(
I-Diagnostic_tool	175	177	FA
I-Diagnostic_tool	177	178	)
I-Diagnostic_tool	179	185	images
O	186	189	and
B-Characteristic	190	197	retinal
I-Characteristic	198	209	morphologic
I-Characteristic	210	218	features
O	219	221	in
B-Diagnostic_tool	222	226	high
I-Diagnostic_tool	226	227	-
I-Diagnostic_tool	227	237	definition
I-Diagnostic_tool	238	245	optical
I-Diagnostic_tool	246	255	coherence
I-Diagnostic_tool	256	266	tomography
I-Diagnostic_tool	267	268	(
I-Diagnostic_tool	268	270	HD
I-Diagnostic_tool	271	274	OCT
I-Diagnostic_tool	274	275	)
I-Diagnostic_tool	276	282	images
O	283	285	in
B-Disease	286	294	diabetic
I-Disease	295	302	macular
I-Disease	303	308	edema
O	308	309	.

O	310	321	Prospective
O	322	327	pilot
O	328	333	study
O	334	337	and
O	338	342	case
O	343	349	series
O	349	350	.

O	351	355	Nine
O	356	367	consecutive
O	368	376	patients
O	377	378	(
O	378	380	10
B-Anatomy	381	385	eyes
O	385	386	)
O	387	391	with
B-Disease	392	400	diabetic
I-Disease	401	408	macular
I-Disease	409	414	edema
O	414	415	.

O	416	419	All
O	420	428	patients
O	429	433	were
O	434	442	examined
O	443	448	using
B-Diagnostic_tool	449	451	FA
O	452	453	(
O	453	456	HRA
O	457	458	2
O	458	459	;
O	460	470	Heidelberg
O	471	482	Engineering
O	482	483	)
O	484	487	and
B-Diagnostic_tool	488	490	HD
I-Diagnostic_tool	491	494	OCT
O	495	496	(
O	496	500	Carl
O	501	506	Zeiss
O	507	514	Meditec
O	514	515	;
O	516	526	resolution
O	526	527	,
O	528	535	512x128
O	536	542	pixels
O	542	543	,
O	544	545	5
O	545	546	.
O	546	549	8x5
O	549	550	.
O	550	551	8
O	552	554	mm
O	554	555	,
O	556	559	and
O	560	564	high
O	564	565	-
O	565	575	resolution
O	576	581	scans
O	582	592	consisting
O	593	595	of
O	596	600	4096
O	601	602	A
O	603	608	scans
O	608	609	)
O	610	612	on
O	613	616	the
O	617	621	same
O	622	625	day
O	625	626	.

O	627	632	Using
O	633	638	Adobe
O	639	648	Photoshop
O	649	650	(
O	650	653	CS2
O	654	661	Version
O	662	663	9
O	663	664	.
O	664	665	0
O	665	666	;
O	667	672	Adobe
O	673	680	Systems
O	681	693	Incorporated
O	693	694	,
O	695	698	San
O	699	703	Jose
O	703	704	,
O	705	707	CA
O	707	708	)
O	709	710	a
O	711	715	grid
O	716	726	containing
O	727	731	15x7
O	732	738	fields
O	739	742	was
O	743	755	superimposed
O	756	758	on
O	759	762	the
B-Diagnostic_tool	763	765	HD
I-Diagnostic_tool	766	769	OCT
I-Diagnostic_tool	770	772	en
I-Diagnostic_tool	773	777	face
I-Diagnostic_tool	778	783	image
O	784	787	and
O	788	789	a
B-Diagnostic_tool	790	794	late
I-Diagnostic_tool	794	795	-
I-Diagnostic_tool	795	800	phase
I-Diagnostic_tool	801	803	FA
I-Diagnostic_tool	804	809	image
O	810	819	according
O	820	822	to
B-Characteristic	823	830	retinal
I-Characteristic	831	840	landmarks
O	840	841	.

O	842	844	In
O	845	849	each
O	850	857	patient
O	857	858	,
O	859	860	a
O	861	873	standardized
O	874	882	analysis
O	883	885	of
O	886	889	105
O	890	899	subfields
O	900	903	was
O	904	913	performed
O	914	916	to
O	917	924	provide
O	925	926	a
O	927	943	characterization
O	944	946	of
O	947	950	the
B-Characteristic	951	955	type
I-Characteristic	956	958	of
I-Characteristic	959	967	vascular
I-Characteristic	968	975	leakage
I-Characteristic	976	978	in
I-Characteristic	979	981	FA
O	982	985	and
O	986	989	the
O	990	1000	associated
B-Characteristic	1001	1008	retinal
I-Characteristic	1009	1020	morphologic
I-Characteristic	1021	1028	changes
O	1029	1031	in
O	1032	1045	corresponding
O	1046	1055	locations
O	1055	1056	.

B-Characteristic	1057	1069	Angiographic
I-Characteristic	1070	1077	leakage
I-Characteristic	1078	1082	type
O	1083	1086	and
B-Characteristic	1087	1097	structural
I-Characteristic	1098	1108	alteration
I-Characteristic	1109	1111	in
I-Characteristic	1112	1119	retinal
I-Characteristic	1120	1131	morphologic
I-Characteristic	1132	1140	features
I-Characteristic	1141	1143	in
I-Characteristic	1144	1147	OCT
O	1147	1148	.

O	1149	1154	There
O	1155	1158	was
O	1159	1160	a
O	1161	1165	high
O	1166	1177	consistency
O	1178	1185	between
B-Diagnostic_tool	1186	1188	FA
O	1189	1192	and
B-Diagnostic_tool	1193	1196	OCT
O	1197	1199	in
O	1200	1203	the
B-Characteristic	1204	1212	petaloid
I-Characteristic	1213	1220	pattern
I-Characteristic	1221	1223	of
I-Characteristic	1224	1241	hyperfluorescence
O	1242	1246	that
O	1247	1257	correlated
O	1258	1262	with
O	1263	1266	the
O	1267	1275	presence
O	1276	1278	of
B-Characteristic	1279	1284	large
I-Characteristic	1285	1291	cystic
I-Characteristic	1292	1298	spaces
I-Characteristic	1299	1301	in
I-Characteristic	1302	1305	the
I-Characteristic	1306	1311	outer
I-Characteristic	1312	1319	nuclear
I-Characteristic	1320	1325	layer
I-Characteristic	1326	1327	(
I-Characteristic	1327	1330	ONL
I-Characteristic	1330	1331	)
I-Characteristic	1332	1335	and
I-Characteristic	1336	1339	the
I-Characteristic	1340	1345	outer
I-Characteristic	1346	1355	plexiform
I-Characteristic	1356	1361	layer
I-Characteristic	1362	1363	(
I-Characteristic	1363	1366	OPL
I-Characteristic	1366	1367	)
O	1368	1372	with
O	1373	1375	or
O	1376	1383	without
B-Symptom	1384	1394	subretinal
I-Symptom	1395	1400	fluid
O	1401	1403	in
O	1404	1406	30
O	1406	1407	.
O	1407	1408	4
O	1408	1409	%
O	1410	1413	and
O	1414	1416	69
O	1416	1417	.
O	1417	1418	6
O	1418	1419	%
O	1420	1422	of
O	1423	1429	graded
O	1430	1436	fields
O	1436	1437	,
O	1438	1450	respectively
O	1450	1451	.

O	1452	1453	A
B-Characteristic	1454	1467	honeycomblike
I-Characteristic	1468	1475	pattern
I-Characteristic	1476	1478	of
I-Characteristic	1479	1496	hyperfluorescence
O	1497	1500	was
O	1501	1511	associated
O	1512	1516	with
B-Characteristic	1517	1525	swelling
I-Characteristic	1526	1529	and
I-Characteristic	1530	1536	cystic
I-Characteristic	1537	1543	spaces
I-Characteristic	1544	1546	in
I-Characteristic	1547	1550	ONL
I-Characteristic	1550	1551	,
I-Characteristic	1552	1555	OPL
I-Characteristic	1555	1556	,
I-Characteristic	1557	1560	the
I-Characteristic	1561	1566	inner
I-Characteristic	1567	1574	nuclear
I-Characteristic	1574	1575	,
I-Characteristic	1576	1579	and
I-Characteristic	1580	1583	the
I-Characteristic	1584	1589	inner
I-Characteristic	1590	1599	plexiform
I-Characteristic	1600	1605	layer
O	1606	1608	in
O	1609	1611	71
O	1611	1612	.
O	1612	1613	4
O	1613	1614	%
O	1615	1617	of
O	1618	1624	graded
O	1625	1631	fields
O	1631	1632	.

B-Characteristic	1633	1640	Diffuse
I-Characteristic	1641	1649	patterns
I-Characteristic	1650	1652	of
I-Characteristic	1653	1670	hyperfluorescence
O	1671	1674	did
O	1675	1678	not
O	1679	1688	correlate
O	1689	1693	with
B-Characteristic	1694	1708	characteristic
I-Characteristic	1709	1716	retinal
I-Characteristic	1717	1724	changes
I-Characteristic	1725	1727	in
I-Characteristic	1728	1730	HD
I-Characteristic	1731	1734	OCT
O	1734	1735	,
O	1736	1739	but
O	1740	1746	rather
O	1747	1753	showed
O	1754	1763	diversity
O	1764	1766	in
O	1767	1770	the
O	1771	1775	type
O	1776	1778	of
O	1779	1790	morphologic
O	1791	1801	alteration
O	1801	1802	.

O	1803	1806	The
O	1807	1815	presence
O	1816	1818	of
B-Symptom	1819	1826	central
I-Symptom	1827	1832	fluid
I-Symptom	1833	1840	pooling
O	1840	1841	,
O	1842	1846	such
O	1847	1849	as
B-Symptom	1850	1860	subretinal
I-Symptom	1861	1866	fluid
O	1866	1867	,
O	1868	1873	could
O	1874	1876	be
O	1877	1887	identified
O	1888	1892	only
O	1893	1895	by
B-Diagnostic_tool	1896	1898	HD
I-Diagnostic_tool	1899	1902	OCT
O	1903	1906	and
O	1907	1910	not
O	1911	1913	by
B-Diagnostic_tool	1914	1916	FA
O	1916	1917	.

O	1918	1920	In
O	1921	1924	the
O	1925	1933	examined
O	1934	1942	patients
O	1942	1943	,
O	1944	1945	a
B-Characteristic	1946	1954	petaloid
I-Characteristic	1955	1962	pattern
I-Characteristic	1963	1966	and
I-Characteristic	1967	1968	a
I-Characteristic	1969	1978	honeycomb
I-Characteristic	1979	1986	pattern
I-Characteristic	1987	1989	of
I-Characteristic	1990	2007	hyperfluorescence
I-Characteristic	2008	2016	observed
I-Characteristic	2017	2019	in
I-Characteristic	2020	2022	FA
O	2023	2027	were
O	2028	2033	found
O	2034	2036	to
O	2037	2046	correlate
O	2047	2049	to
B-Characteristic	2050	2064	characteristic
I-Characteristic	2065	2072	changes
I-Characteristic	2073	2075	in
I-Characteristic	2076	2078	HD
I-Characteristic	2079	2082	OCT
I-Characteristic	2082	2083	,
O	2084	2091	whereas
O	2092	2093	a
B-Characteristic	2094	2101	diffuse
I-Characteristic	2102	2109	leakage
I-Characteristic	2110	2117	pattern
O	2118	2121	was
O	2122	2132	associated
O	2133	2137	with
B-Characteristic	2138	2148	nonuniform
I-Characteristic	2149	2156	changes
I-Characteristic	2157	2159	in
I-Characteristic	2160	2167	retinal
I-Characteristic	2168	2179	morphologic
I-Characteristic	2180	2188	features
O	2188	2189	.

O	2190	2193	The
O	2194	2200	author
O	2200	2201	(
O	2201	2202	s
O	2202	2203	)
O	2204	2208	have
O	2209	2211	no
O	2212	2223	proprietary
O	2224	2226	or
O	2227	2237	commercial
O	2238	2246	interest
O	2247	2249	in
O	2250	2253	any
O	2254	2263	materials
O	2264	2273	discussed
O	2274	2276	in
O	2277	2281	this
O	2282	2289	article
O	2289	2290	.
